Skip to main content

Table 1 Patient characteristics at the start of first-line chemoradiotherapy

From: Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study

Characteristics Platinum group non-Platinum group P-value
n % n %
Overall 119   201   
Age (years)
 Median (range) 63 (33—81) 65 (44—80)  
  ≥ 75 8 6.7 15 7.5 1.0
  < 75 111 93.3 186 92.5
Sex
 Female 18 15.1 25 12.4 0.50
 Male 101 84.9 176 87.6
Smoking status
 Current 68 57.1 115 57.2 1.0
 Former 44 37.0 75 37.3
 Never 7 5.9 11 5.5
Respiratory comorbidity
 Yes 43 36.1 78 38.8 0.72
 No 76 63.9 123 61.2
ECOG PS
 0 66 55.5 100 49.8 0.41
 1 49 41.2 97 48.3
 2 4 3.4 4 2.0
Histology
 Adenocarcinoma 51 42.9 85 42.3 0.99
 Squamous cell carcinoma 53 44.5 89 44.3
 Other 15 12.6 27 13.4
Clinical stage (UICC-TNM classification, 7th edition)
 IIIA 60 50.4 95 47.3 0.64
 IIIB 59 49.6 106 52.7
  1. ECOG PS Eastern Cooperative Oncology Group performance status, UICC Union for International Cancer Control
  2. All P values were calculated using the Fisher’s exact test